Efficacy and safety of nab-paclitaxel plus gemcitabine (AG) vs. FOLFIRINOX (FFX) as first line chemotherapy for metastatic pancreatic cancer (mPC): Retrospective analysis

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii245
Main Authors Lee, K., Hwang, I., Kang, J., Yoo, C., Kim, K.-P., Jeong, J.H., Chang, H.-M., Ryoo, B.-Y.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy282.108